ZNF582 and breast carcinoma: To explore the signal pathways and cellular functions of ZNF582-AS1, we developed two molecular signatures of ZNF582-AS1 in breast cancer, one based on its transcriptome and another involving its methylome, which were considered to represent high and low expression of ZNF582-AS1, respectively, and to presumably be complementary to one another in cell signaling.